Insider Transactions in Q3 2023 at Bristol Myers Squibb CO (BMY)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 24
2023
|
Ann Powell EVP, Chief Human Resources |
SELL
Open market or private sale
|
Direct |
17,986
-39.22%
|
$1,097,146
$61.25 P/Share
|
|
Aug 03
2023
|
Robert M Plenge EVP, Chief Research Officer |
SELL
Open market or private sale
|
Direct |
732
-10.01%
|
$44,652
$61.14 P/Share
|
|
Jul 01
2023
|
Michelle Weese EVP, Corporate Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
682
-16.49%
|
$42,966
$63.95 P/Share
|
|
Jul 01
2023
|
Michelle Weese EVP, Corporate Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
1,885
+31.31%
|
-
|
|
Jul 01
2023
|
Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,787
-9.2%
|
$301,581
$63.95 P/Share
|
|
Jul 01
2023
|
Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. |
BUY
Exercise of conversion of derivative security
|
Direct |
9,357
+15.24%
|
-
|